Ondansetron ODT 8 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FE9GV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,727
Award facts
- Contract value 100% obligated
- $2,727.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,727.46 to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30. The contract, which is competitively awarded with no set-aside designation, utilizes firm fixed-price pricing and is scheduled for completion by January 15, 2026. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at up to $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company supplies a comprehensive range of pharmaceutical products, medical supplies, vaccines, and specialized healthcare commodities across multiple therapeutic domains. The IDC with DLA Troop Support Medical represents a significant component of the Defense Logistics Agency's pharmaceutical supply chain and demonstrates the contractor's extensive capability to fulfill government requirements for essential medications and medical commodities on a global scale.
Quick answers
Who was awarded contract SPE2DR26FE9GV?
SPE2DR26FE9GV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FE9GV worth?
The government has obligated $2,727 on SPE2DR26FE9GV.
Is contract SPE2DR26FE9GV an order under another contract?
Yes. SPE2DR26FE9GV is a delivery order under SPE2DR25D3104, an indefinite delivery contract.
Was contract SPE2DR26FE9GV competed?
The extent of competition for SPE2DR26FE9GV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award